These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2869041)

  • 1. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
    Sengupta S; Lokhandwala MF
    J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA; Sabouni MH; Ansari AF; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of dopamine receptor subtypes in the hypotensive action of SK&F 85174 in anesthetized rats.
    Sowinski BA; Lokhandwala MF
    J Auton Pharmacol; 1987 Jun; 7(2):105-9. PubMed ID: 2888767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.
    Cavero I; Thiry C; Pratz J; Lawson K
    Clin Exp Hypertens A; 1987; 9(5-6):931-52. PubMed ID: 2887315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G; Demenge P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):548-55. PubMed ID: 1724532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG; Lefebvre RA; Vanderniepen P
    Br J Pharmacol; 1987 Jul; 91(3):493-501. PubMed ID: 2886174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
    Lefevre-Borg F; Lorrain J; Lechaire J; Thiry C; Lhoste F; Hicks PE; Cavero I
    Fundam Clin Pharmacol; 1987; 1(3):179-200. PubMed ID: 2892767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive and regional haemodynamic effects of fenoldopam and quinpirole in the anaesthetized rat.
    Van der Niepen P; Dupont AG; Finne E; Six RO
    J Hypertens Suppl; 1988 Dec; 6(4):S687-9. PubMed ID: 2907350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of SKF 82526 and LY 171555 on presynaptic (DA2) and postsynaptic (DA1) dopamine receptors in rat kidney.
    Lokhandwala MF; Steenberg ML
    J Auton Pharmacol; 1984 Dec; 4(4):273-7. PubMed ID: 6152269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological characterization of ganglionic dopamine receptors.
    Sabouni MH; Alkadhi KA; Lokhandwala MF
    Clin Exp Hypertens A; 1987; 9(5-6):873-87. PubMed ID: 2887312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of cyclic-AMP in the hypotensive response to fenoldopam but not to quinpirole in the anaesthetized rat.
    Hegde SS; Lokhandwala MF
    J Auton Pharmacol; 1988 Mar; 8(1):63-8. PubMed ID: 2455721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
    Lokhandwala MF; Watkins HO; Sabouni MH; Alkadhi KA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):337-44. PubMed ID: 2862275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of selective dopamine receptor agonists in the rat and dog.
    Hieble JP; Owen DA; Harvey CA; Blumberg AL; Valocik RE; DeMarinis RM
    Clin Exp Hypertens A; 1987; 9(5-6):889-912. PubMed ID: 2887313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective antagonism of renal hemodynamic changes induced by dopamine, DPDA, fenoldopam and quinpirole in the rat.
    Rosenkranz RP; McClelland DL
    Proc West Pharmacol Soc; 1987; 30():25-36. PubMed ID: 2888129
    [No Abstract]   [Full Text] [Related]  

  • 17. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
    Lokhandwala MF; Sabouni MH
    J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
    Rump LC; Schwertfeger E; Schuster MJ; Schaible U; Frankenschmidt A; Schollmeyer PJ
    Kidney Int; 1993 Jan; 43(1):197-204. PubMed ID: 8094472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
    Kohli JD; Glock D; Goldberg LI
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both DA1 and DA2 receptor agonists are necessary to inhibit NaKATPase activity in proximal tubules from rat kidney.
    Bertorello A; Aperia A
    Acta Physiol Scand; 1988 Mar; 132(3):441-3. PubMed ID: 2906504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.